E. Bolesta

发表

Delivery Gene IL-15 and IL-21 Combined with Expressing the HIV-1 Env Glycoprotein when Immune Responses Induced by DNA Vaccine Increased Level and Longevity of Protective

L. Stamatatos, P. Shrikant, D. Kozbor, 2006 .

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design

M. Manjili, M. Grimes, M. Kmieciak, 2008, Cancer Immunology, Immunotherapy.

DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.

A. Kolinski, P. Rotkiewicz, S. Ferrone, 2005, Cancer research.

Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery1

L. Stamatatos, P. Shrikant, D. Kozbor, 2006, The Journal of Immunology.

Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 Isolates

G. Trinchieri, A. Sieron, A. Srinivasan, 2002, Journal of Virology.

Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.

A. Srinivasan, D. Kozbor, A. Wierzbicki, 2005, Virology.

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.

K. Komuro, D. Kozbor, Y. Kaneko, 2004, Virology.

Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.

D. Kozbor, Y. Kaneko, D. Kmieciak, 2001, Journal of human virology.